Dr Xiaowei Wang, Baker Heart and Diabetes Institute; Melbourne, Australia
Dr Wang's research focuses on providing better diagnostic imaging, side-effect free targeted drug delivery and theranostic (concurrent therapy & diagnostics) approaches for a range of cardiovascular diseases.
The team’s research involves:
Biotechnology for genetic design and engineering of recombinant proteins, as well as antibody-drug fusion therapeutics for cardiovascular diseases
Biomaterials selection, design, functionalisation and generation of innovative nano-/micro-particles
Novel conjugations of antibody-particles using biological and/or chemical coupling
Molecular imaging of cardiovascular diseases using ultrasound, MRI, PET, MicroCT, fluorescence and photoacoustic imaging